gmp
gmp

Overview of Digoxin

Client Email Product
DSSTox_CID_2934
  • Synopsis

  • Chemistry

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

0

API Market Place

INTERMEDIATES

0

DOSSIERs
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

Dossiers Market Place

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

MEDIA

Blog

News

REFERENCE STANDARD

EDQM

USP

JP

Other Listed Suppliers

SERVICES

0

  • WHO-GMP
Applications: Direct compression for modified release dosage forms
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Solid Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Microcrystalline Cellulose, Ethylcellulose , Hydroxypropyl methyl cellulose K4M, Hydroxypropyl Cellulose, Colloidal Silicon Dioxide, Maize Starch, Magnesium Stearate and Talc
  • FDA
Applications: Immediate Release
Ingredient(s): Starch
Dosage Form: Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements
Technical Specifications: Not Available
  • FDA
Applications: Immediate Release
Dosage Form: Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements
Technical Specifications: Not Available
  • FDA
Applications: Immediate Release
Dosage Form: Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements
Technical Specifications: Not Available
  • WHO-GMP
Applications: Direct compression for modified release dosage forms
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Solid Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Microcrystalline Cellulose, Ethylcellulose, Hydroxypropyl methyl cellulose K100Microcrystalline Cellulose, Ethylcellulose, Hydroxypropyl methyl cellulose K100M, Hydroxypropyl Cellulose, Colloidal Silicon Dioxide and Magnesium StearateM, Hydroxypropyl Cell
    Applications: These spheres can be used as an inert base for modified release formulations promoting consistency and uniformity of release profile thus ensuring a uniform therapeutic response.
    Dosage Form: Tablet
    More Info on Category: Controlled & Modified Release
    Route of Administration (Grade): Oral
    Pharmacopoeia Reference: Particle Sizes - #20 – #30, #30 – #40 and #40 – #60
    Technical Specifications: Not Available
      Applications: HiCel MCC Spheres are extremely versatile which is used for controlled release or sustained release formulations.
      Dosage Form: Tablet
      More Info on Category: Controlled & Modified Release
      Route of Administration (Grade): Oral
      Pharmacopoeia Reference: Not Available
      Technical Specifications: Not Available
      left grey arrow
      right gray arrow
      • TABLET;ORAL - 0.0625MG
      • TABLET;ORAL - 0.125MG
      • TABLET;ORAL - 0.1875MG
      • TABLET;ORAL - 0.25MG
      • ELIXIR;ORAL - 0.05MG/ML
      • INJECTABLE;INJECTION - 0.1MG/ML
      • INJECTABLE;INJECTION - 0.25MG/ML
      Ask Us for Pharmaceutical Supplier and Partner
      Ask Us, Find A Supplier / Partner
      No Commissions, No Strings Attached, Get Connected for FREE

      What are you looking for?

      How can we help you?

      The request can't be empty

      Please read our Privacy Policy carefully

      You must agree to the privacy policy

      The name can't be empty
      The company can't be empty.
      The email can't be empty Please enter a valid email.
      The mobile can't be empty